The effect of Eye Movement Desensitization and Reprocessing (EMDR) on Illness Anxiety Disorder (IAD): two multiple baseline n-of-1 trials across seven participants each.

Recruiting

• Conditions: hypochondria; illness anxiety disorder; 10002861

• Registration Number: NL-OMON51800
• Lead Sponsor: PEP Groep (Praktijk Eerstelijns Psychologie)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 14

Inclusion Criteria

>18 years
DSM-5 diagnosis of an Illness Anxiety Disorder

Exclusion Criteria

Participants will be excluded from participating in this study if they are
currently under treatment for their IAD or receive any psychological or
pharmaceutical treatment for another disorder or problem. Exceptions will be
made for patients who are currently treated with selective serotonin reuptake
inhibitors (SSRI*s) and on a stable dose for the last 3 months. Additionally,
participants will be excluded if they can*t read and comprehend Dutch language,
and if they are unable to give informed consent because of mental incapacity.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The daily Idiopathic illness anxiety scale (IIAS).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>SCID-5-S, SCL-90 en BDI-II-NL, WI, IAS and PCL-5</p><br>